| Year |
Citation |
Score |
| 2019 |
DeSousa M, Reeve CL, Peterman AH. Development and Initial Validation of the Perceived Scarcity Scale (PScS). Stress and Health : Journal of the International Society For the Investigation of Stress. PMID 31692256 DOI: 10.1002/Smi.2908 |
0.461 |
|
| 2019 |
Peterman AH. Religious beliefs influencing aggressive end-of-life care preferences: A measurement advance and continued challenges. Cancer. PMID 30825380 DOI: 10.1002/Cncr.31945 |
0.35 |
|
| 2014 |
Anders C, Deal AM, Abramson V, Liu MC, Storniolo AM, Carpenter JT, Puhalla S, Nanda R, Melhem-Bertrandt A, Lin NU, Kelly Marcom P, Van Poznak C, Stearns V, Melisko M, Smith JK, ... ... Peterman A, et al. TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases. Breast Cancer Research and Treatment. 146: 557-66. PMID 25001612 DOI: 10.1007/S10549-014-3039-Y |
0.346 |
|
| 2014 |
Peterman AH, Reeve CL, Winford EC, Cotton S, Salsman JM, McQuellon R, Tsevat J, Campbell C. Measuring meaning and peace with the FACIT-spiritual well-being scale: distinction without a difference? Psychological Assessment. 26: 127-37. PMID 24188147 DOI: 10.1037/A0034805 |
0.57 |
|
| 2013 |
Salsman JM, Victorson D, Choi SW, Peterman AH, Heinemann AW, Nowinski C, Cella D. Development and validation of the positive affect and well-being scale for the neurology quality of life (Neuro-QOL) measurement system. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 22: 2569-80. PMID 23526093 DOI: 10.1007/S11136-013-0382-0 |
0.49 |
|
| 2013 |
Stinchcombe TE, Roder J, Peterman AH, Grigorieva J, Lee CB, Moore DT, Socinski MA. A retrospective analysis of VeriStrat status on outcome of a randomized phase II trial of first-line therapy with gemcitabine, erlotinib, or the combination in elderly patients (age 70 years or older) with stage IIIB/IV non-small-cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 8: 443-51. PMID 23370367 DOI: 10.1097/Jto.0B013E3182835577 |
0.305 |
|
| 2013 |
Canada AL, Fitchett G, Murphy PE, Stein K, Portier K, Crammer C, Peterman AH. Racial/ethnic differences in spiritual well-being among cancer survivors. Journal of Behavioral Medicine. 36: 441-53. PMID 22752250 DOI: 10.1007/S10865-012-9439-8 |
0.395 |
|
| 2013 |
Stinchcombe TE, Roder J, Peterman AH, Grigorieva J, Lee CB, Moore DT, Socinski MA. Erratum: A Retrospective Analysis of VeriStrat Status on Outcome of a Randomized Phase II Trial of First-line Therapy with Gemcitabine, Erlotinib, or the Combination in Elderly Patients (Age ≥ 70 years) with Stage IIIB/IV Non-Small Cell Lung Cancer (Journal of Thoracic Oncology (2013) 8 (443-451)) Journal of Thoracic Oncology. 8. DOI: 10.1097/Jto.0B013E31829765D2 |
0.315 |
|
| 2012 |
Cella D, Lai JS, Nowinski CJ, Victorson D, Peterman A, Miller D, Bethoux F, Heinemann A, Rubin S, Cavazos JE, Reder AT, Sufit R, Simuni T, Holmes GL, Siderowf A, et al. Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology. Neurology. 78: 1860-7. PMID 22573626 DOI: 10.1212/Wnl.0B013E318258F744 |
0.469 |
|
| 2012 |
Gershon RC, Lai JS, Bode R, Choi S, Moy C, Bleck T, Miller D, Peterman A, Cella D. Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 21: 475-86. PMID 21874314 DOI: 10.1007/S11136-011-9958-8 |
0.428 |
|
| 2011 |
Cella D, Nowinski CJ, Peterman A, Victorson DE, Miller D, Lai J, Moy C. The Neurology Quality-of-Life Measurement Initiative Archives of Physical Medicine and Rehabilitation. 92. PMID 21958920 DOI: 10.1016/J.Apmr.2011.01.025 |
0.457 |
|
| 2011 |
Stinchcombe TE, Peterman AH, Lee CB, Moore DT, Beaumont JL, Bradford DS, Bakri K, Taylor M, Crane JM, Schwartz G, Hensing TA, McElroy E, Niell HB, Harper HD, Pal S, et al. A randomized phase II trial of first-line treatment with gemcitabine, erlotinib, or gemcitabine and erlotinib in elderly patients (age ≥70 years) with stage IIIB/IV non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 6: 1569-77. PMID 21716146 DOI: 10.1097/Jto.0B013E3182210430 |
0.342 |
|
| 2010 |
Murphy PE, Canada AL, Fitchett G, Stein K, Portier K, Crammer C, Peterman AH. An examination of the 3-factor model and structural invariance across racial/ethnic groups for the FACIT-Sp: a report from the American Cancer Society's Study of Cancer Survivors-II (SCS-II). Psycho-Oncology. 19: 264-72. PMID 19367561 DOI: 10.1002/Pon.1559 |
0.386 |
|
| 2009 |
Philip EJ, Merluzzi TV, Peterman A, Cronk LB. Measurement accuracy in assessing patient's quality of life: to weight or not to weight domains of quality of life. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 18: 775-82. PMID 19496020 DOI: 10.1007/S11136-009-9492-0 |
0.402 |
|
| 2009 |
Rao D, Choi SW, Victorson D, Bode R, Peterman A, Heinemann A, Cella D. Measuring stigma across neurological conditions: the development of the stigma scale for chronic illness (SSCI). Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 18: 585-95. PMID 19396572 DOI: 10.1007/S11136-009-9475-1 |
0.468 |
|
| 2008 |
Canada AL, Murphy PE, Fitchett G, Peterman AH, Schover LR. A 3-factor model for the FACIT-Sp. Psycho-Oncology. 17: 908-16. PMID 18095260 DOI: 10.1002/Pon.1307 |
0.39 |
|
| 2008 |
Butt Z, Wagner LI, Beaumont JL, Paice JA, Peterman AH, Shevrin D, Von Roenn JH, Carro G, Straus JL, Muir JC, Cella D. Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice. Journal of Pain and Symptom Management. 35: 20-30. PMID 17959345 DOI: 10.1016/J.Jpainsymman.2007.02.040 |
0.377 |
|
| 2008 |
Wagner LI, Beaumont JL, Ding B, Malin J, Peterman A, Calhoun E, Cella D. Measuring health-related quality of life and neutropenia-specific concerns among older adults undergoing chemotherapy: Validation of the Functional Assessment of Cancer Therapy-Neutropenia (FACT-N) Supportive Care in Cancer. 16: 47-56. PMID 17619911 DOI: 10.1007/S00520-007-0270-7 |
0.461 |
|
| 2007 |
Perez L, Huang J, Jansky L, Nowinski C, Victorson D, Peterman A, Cella D. Using focus groups to inform the Neuro-QOL measurement tool: exploring patient-centered, health-related quality of life concepts across neurological conditions. Journal of Neuroscience Nursing. 39: 342-353. PMID 18186419 DOI: 10.1097/01376517-200712000-00005 |
0.477 |
|
| 2007 |
Yi MS, Mrus JM, Mueller CV, Luckhaupt SE, Peterman AH, Puchalski CM, Tsevat J. Self-rated health of primary care house officers and its relationship to psychological and spiritual well-being. Bmc Medical Education. 7: 9. PMID 17474998 DOI: 10.1186/1472-6920-7-9 |
0.331 |
|
| 2007 |
Rosenbloom SK, Victorson DE, Hahn EA, Peterman AH, Cella D. Assessment is not enough: a randomized controlled trial of the effects of HRQL assessment on quality of life and satisfaction in oncology clinical practice. Psycho-Oncology. 16: 1069-79. PMID 17342789 DOI: 10.1002/Pon.1184 |
0.43 |
|
| 2007 |
Lai J, Kupst MJ, Cella D, Brown SR, Peterman A, Goldman S. Using Q-methodology to understand perceived fatigue reported by adolescents with cancer. Psycho-Oncology. 16: 437-447. PMID 16944444 DOI: 10.1002/Pon.1071 |
0.346 |
|
| 2006 |
Cotton S, Puchalski CM, Sherman SN, Mrus JM, Peterman AH, Feinberg J, Pargament KI, Justice AC, Leonard AC, Tsevat J. Spirituality and religion in patients with HIV/AIDS. Journal of General Internal Medicine. 21: S5-13. PMID 17083501 DOI: 10.1111/J.1525-1497.2006.00642.X |
0.339 |
|
| 2006 |
Szaflarski M, Ritchey PN, Leonard AC, Mrus JM, Peterman AH, Ellison CG, McCullough ME, Tsevat J. Modeling the effects of spirituality/religion on patients' perceptions of living with HIV/AIDS. Journal of General Internal Medicine. 21: S28-38. PMID 17083497 DOI: 10.1111/J.1525-1497.2006.00646.X |
0.374 |
|
| 2005 |
Lai J, Cella D, Peterman A, Barocas J, Goldman S. Anorexia/cachexia-related quality of life for children with cancer Cancer. 104: 1531-1539. PMID 16088963 DOI: 10.1002/Cncr.21315 |
0.423 |
|
| 2005 |
Daugherty CK, Fitchett G, Murphy PE, Peterman AH, Banik DM, Hlubocky F, Tartaro J. Trusting God and medicine: spirituality in advanced cancer patients volunteering for clinical trials of experimental agents. Psycho-Oncology. 14: 135-46. PMID 15386780 DOI: 10.1002/Pon.829 |
0.381 |
|
| 2004 |
Eton DT, Cella D, Yost KJ, Yount SE, Peterman AH, Neuberg DS, Sledge GW, Wood WC. A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. Journal of Clinical Epidemiology. 57: 898-910. PMID 15504633 DOI: 10.1016/J.Jclinepi.2004.01.012 |
0.327 |
|
| 2003 |
Gershon R, Cella D, Dineen K, Rosenbloom S, Peterman A, Lai J. Item response theory and health-related quality of life in cancer. Expert Review of Pharmacoeconomics & Outcomes Research. 3: 783-791. PMID 19807355 DOI: 10.1586/14737167.3.6.783 |
0.5 |
|
| 2003 |
Cella D, Peterman A, Hudgens S, Webster K, Socinski MA. Measuring the side effects of taxane therapy in oncology: The Functional Assessment of Cancer therapy-taxane (FACT-taxane) Cancer. 98: 822-831. PMID 12910528 DOI: 10.1002/Cncr.11578 |
0.472 |
|
| 2003 |
Hensing TA, Peterman AH, Schell MJ, Lee JH, Socinski MA. The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, Stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel. Cancer. 98: 779-88. PMID 12910523 DOI: 10.1002/Cncr.11548 |
0.341 |
|
| 2002 |
Chang CH, Cella D, Masters GA, Laliberte N, O'Brien P, Peterman A, Shervin D. Real-time clinical application of quality-of-life assessment in advanced lung cancer. Clinical Lung Cancer. 4: 104-9. PMID 14653866 DOI: 10.3816/Clc.2002.N.020 |
0.417 |
|
| 2002 |
Cella D, Eton DT, Lai JS, Peterman AH, Merkel DE. Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. Journal of Pain and Symptom Management. 24: 547-61. PMID 12551804 DOI: 10.1016/S0885-3924(02)00529-8 |
0.428 |
|
| 2002 |
Matthews AK, Peterman AH, Delaney P, Menard L, Brandenburg D. A qualitative exploration of the experiences of lesbian and heterosexual patients with breast cancer. Oncology Nursing Forum. 29: 1455-62. PMID 12432416 DOI: 10.1188/02.Onf.1455-1462 |
0.361 |
|
| 2002 |
Socinski MA, Schell MJ, Bakri K, Peterman A, Lee JH, Unger P, Yates S, Hudgens S, Kies MS. Second-line, low-dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel. Cancer. 95: 1265-73. PMID 12216094 DOI: 10.1002/Cncr.10835 |
0.308 |
|
| 2002 |
Peterman AH, Fitchett G, Brady MJ, Hernandez L, Cella D. Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy--Spiritual Well-being Scale (FACIT-Sp). Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine. 24: 49-58. PMID 12008794 DOI: 10.1207/S15324796Abm2401_06 |
0.518 |
|
| 2002 |
Cella D, Lai J, Chang C, Peterman A, Slavin M. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer. 94: 528-538. PMID 11900238 DOI: 10.1002/Cncr.10245 |
0.38 |
|
| 2002 |
Socinski MA, Schell MJ, Peterman A, Bakri K, Yates S, Gitten R, Unger P, Lee J, Lee JH, Tynan M, Moore M, Kies MS. Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 1335-43. PMID 11870177 DOI: 10.1200/Jco.20.5.1335 |
0.338 |
|
| 2002 |
Cella D, Hughes C, Peterman A, Chang CH, Peshkin BN, Schwartz MD, Wenzel L, Lemke A, Marcus AC, Lerman C. A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychology. 21: 564-572. DOI: 10.1037/0278-6133.21.6.564 |
0.336 |
|
| 2001 |
Peterman A, Cella D, Glandon G, Dobrez D, Yount S. Mucositis in head and neck cancer: economic and quality-of-life outcomes. Journal of the National Cancer Institute. Monographs. 45-51. PMID 11694566 DOI: 10.1093/Oxfordjournals.Jncimonographs.A003440 |
0.432 |
|
| 1999 |
Brady MJ, Peterman AH, Fitchett G, Mo M, Cella D. A case for including spirituality in quality of life measurement in oncology. Psycho-Oncology. 8: 417-28. PMID 10559801 DOI: 10.1002/(Sici)1099-1611(199909/10)8:5<417::Aid-Pon398>3.0.Co;2-4 |
0.457 |
|
| 1998 |
D'Antonio LL, Long SA, Zimmerman GJ, Peterman AH, Petti GH, Chonkich GD. Relationship between quality of life and depression in patients with head and neck cancer. The Laryngoscope. 108: 806-11. PMID 9628493 DOI: 10.1097/00005537-199806000-00006 |
0.425 |
|
| 1997 |
Peterman AH, Cella D, Mo F, McCain N. Psychometric validation of the revised functional assessment of human immunodeficiency virus infection (FAHI) quality of life instrument Quality of Life Research. 6: 572-584. PMID 9330556 DOI: 10.1023/A:1018416317546 |
0.409 |
|
| 1996 |
Peterman AH, Cella DF. Health-Related Quality of Life: Research, Regulatory, and Industry Perspectives. Psyccritiques. 41. DOI: 10.1037/003271 |
0.418 |
|
| Show low-probability matches. |